Vik Bajaj, Managing Director at Foresite Capital, is a savvy leader at the intersection of biotech and AI. In this discussion, he shares the remarkable launch of Xaira Therapeutics with $1 billion in funding. The conversation delves into how advanced computing is transforming drug development, the challenges of cancer screening tests, and the evolving regulatory landscape. Bajaj emphasizes the critical role of data in innovating healthcare solutions and the importance of collaboration across diverse disciplines in the biotech sector.